Effect of Psycho-education on Gestational Weight Gain and Anxiety/Depression in Obese Pregnant Women
1 other identifier
interventional
180
1 country
3
Brief Summary
Prepregnancy obesity, defined as a body mass index (BMI) of 30kg/m² or more, shows a strong association with pregnancy and birth complications for both the mother and her child. Most consequently reported maternal risks include an increased risk for gestational diabetes, hypertension and pre-eclampsia, increased incidence of induction of labour, operative delivery, postpartum haemorrhage, anaesthetic risks as well as risk for infections and thromboembolic complications. Fetal risks include miscarriage, neural-tube defects, heart defects, macrosomia and stillbirth. Initiation and continuation of breastfeeding is more complicated in obese women than in normal weight women. Also in later life chronic diseases can put the mother and her baby's health at risk. The Institute Of Medicine (IOM) guidelines suggest a gestational weight gain (GWG) to be limited to 5 - 9 kg (11-19,8 lb) in obese women in order to minimize the synergetic negative health consequences of excessive weight gain for both the obese mother and her child. Preventing excessive weight gain during pregnancy and postpartum weight retention is also important in the prevention of overweight and obesity among women of reproductive age. Obese women in general have a poor diet quality and are more exposed to psychosocial factors like anxiety and feelings of depression than normal weight women. The aim of this project is to perform a randomized controlled trial (RCT) in order to evaluate the effects of life-style intervention (psycho-education by a midwife during 4 prenatal sessions) on pregnancy and birth outcomes. Main dependent variables are gestational weight gain and anxiety and depression. Obesity is a modifiable risk factor and optimizing an adequate gestational weight gain with attention to psycho-social factors, can reduce the need for adverse perinatal outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2008
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 30, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedFirst Posted
Study publicly available on registry
April 6, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedDecember 6, 2011
July 1, 2008
3.1 years
March 30, 2011
December 5, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Gestational weight gain
Weight just before delivery minus prepregnancy weight
For the duration of pregnancy, an expected average of 40 weeks
Secondary Outcomes (1)
Evolutions in anxiety and depression during pregnancy
During pregnancy on fixed time points: trimester 1 (before 15 weeks of gestation), trimester 2 (between 18 and 28 weeks of gestation) and trimester 3 (between 30 - 34 weeks of gestation)
Study Arms (3)
Written information via brochure
EXPERIMENTALWritten information by a brochure
standard care
NO INTERVENTIONstandard prenatal care
Lifestyle counseling
EXPERIMENTALPsycho-education based on principles of motivational interviewing and positive reinforcement
Interventions
4 prenatal sessions based on principles of motivational interviewing and positive reinforcement
Eligibility Criteria
You may qualify if:
- Less than 15 weeks pregnant
You may not qualify if:
- Multiple pregnancy
- Preexisting diabetes
- Primary need for nutritional advice
- Inadequate knowledge of Dutch language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Limburg Catholic University Collegelead
- PHL University Collegecollaborator
Study Sites (3)
St-Jans Hospital ZOL
Genk, Limburg, 3600, Belgium
Jessa Hospital
Hasselt, Limburg, 3500, Belgium
SFZ
Heusden, Limburg, 3550, Belgium
Study Officials
- STUDY DIRECTOR
Roland Devlieger, PhD, MD
Universitaire Ziekenhuizen KU Leuven
- STUDY DIRECTOR
Bea Van den Bergh, PhD
University of Tilburg (Nl)
- STUDY DIRECTOR
Ingrid Witters, PhD, MD
Universitaire Ziekenhuizen KU Leuven
- PRINCIPAL INVESTIGATOR
Annick Bogaerts, MW, MSc, PhDstudent
KHLim PHL
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 30, 2011
First Posted
April 6, 2011
Study Start
March 1, 2008
Primary Completion
April 1, 2011
Study Completion
December 1, 2013
Last Updated
December 6, 2011
Record last verified: 2008-07